This analysis was completed To guage the likely of your CPPs with tumor-focusing on properties to deliver a cytotoxic payload to HCC cells. We explored employing a CXCR4-targeting peptide, T22, fused with cytotoxic peptide PE24, to be a novel therapeutic strategy for CXCR4+ HCC cells. T22 was picked out as https://saeedq639fko3.wikijm.com/user